Eagle Pharmaceuticals, Inc. (EGRX) Trades at $58.84 After Triangle; TREND MICRO TOK (TMICF) Shorts Raised By 23.15%

Eagle Pharmaceuticals, Inc. (EGRX) formed triangle with $54.72 target or 7.00% below today’s $58.84 share price. Eagle Pharmaceuticals, Inc. (EGRX) has $877.99 million valuation. The stock decreased 0.14% or $0.08 during the last trading session, reaching $58.84. About 111,488 shares traded. Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) has risen 79.40% since January 21, 2017 and is uptrending. It has outperformed by 62.70% the S&P500.

TREND MICRO INCORPORATED TOK (OTCMKTS:TMICF) had an increase of 23.15% in short interest. TMICF’s SI was 161,200 shares in January as released by FINRA. Its up 23.15% from 130,900 shares previously. It closed at $58.37 lastly. It is down 0.00% since January 21, 2017 and is . It has underperformed by 16.70% the S&P500.

Among 4 analysts covering Eagle Pharma (NASDAQ:EGRX), 3 have Buy rating, 1 Sell and 0 Hold. Therefore 75% are positive. Eagle Pharma had 20 analyst reports since July 29, 2015 according to SRatingsIntel. Mizuho downgraded Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) on Monday, June 20 to “Neutral” rating. On Wednesday, November 2 the stock rating was maintained by William Blair with “Outperform”. The rating was maintained by Piper Jaffray on Wednesday, August 9 with “Buy”. RBC Capital Markets maintained the stock with “Buy” rating in Friday, September 1 report. The firm earned “Underperform” rating on Monday, January 9 by Mizuho. The firm earned “Sell” rating on Wednesday, August 9 by Mizuho. As per Monday, December 18, the company rating was maintained by Mizuho. The company was maintained on Tuesday, May 10 by RBC Capital Markets. Mizuho maintained the shares of EGRX in report on Thursday, October 26 with “Sell” rating. As per Thursday, November 3, the company rating was upgraded by Mizuho.

Analysts await Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) to report earnings on March, 7. They expect $1.19 earnings per share, down 66.19% or $2.33 from last year’s $3.52 per share. EGRX’s profit will be $17.76M for 12.36 P/E if the $1.19 EPS becomes a reality. After $1.07 actual earnings per share reported by Eagle Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 11.21% EPS growth.

Trend Micro Incorporated develops and sells security solutions primarily in Japan. The company has market cap of $7.64 billion. The Company’s home products include PC, Mac, and Android and iOS device protection products, as well as password management, virus and Spyware removal, PC security health check, and PC tune up products. It has a 28.5 P/E ratio. The firm also offers hybrid cloud security solutions, such as data center, cloud, and virtualization security products; network security solutions, including integrated advanced threat prevention and advanced threat detection solutions; user protection solutions comprising endpoint and gateway suites, endpoint security, email security, Web security, SaaS application security, and forensics; and support services.